X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Glenmark Pharma Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Glenmark Pharma Quarterly Results   (GLPH)

Here are the latest quarterly results of Glenmark Pharma. For more details, see the Glenmark Pharma financial fact sheet and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Glenmark Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m16,47718,74617,56422,81319,43122,24125,35024,572 
Other income Rs m5482111775918146513 
Turnover Rs m16,53118,75417,58522,92920,19022,25925,49625,085 
Expenses Rs m12,88214,72813,86619,78615,64017,75317,70020,133 
Gross profit Rs m3,5964,0193,6983,0283,7914,4517,6502,603 
Depreciation Rs m697634559628642687625689 
Interest Rs m419426469475430629617697 
Profit before tax Rs m2,5332,9672,6922,0423,4773,1546,5531,730 
Tax Rs m7519629923271,2099181,782107 
Profit after tax Rs m1,7822,0041,6991,7152,2682,2364,7701,623 
Gross profit margin %21.821.421.113.319.520.030.210.6 
Effective tax rate %29.632.436.916.034.829.127.26.2 
Net profit margin %10.810.79.77.511.710.118.86.6 
Diluted EPS Rs 6.6 7.4 6.3 6.3 8.4 8.2 17.6 6.0  
Diluted EPS (TTM) Rs 24.2 25.5 27.5 26.5 28.3 29.2 40.5 40.2  
 Subscriber Feature View View View View View View View View  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  SUN PHARMA  NATCO PHARMA  

Compare GLENMARK PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  SUN PHARMA  NATCO PHARMA  

Compare GLENMARK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty Hovers Near 10,000 Mark; Energy Stocks Witness Buying(01:30 pm)

After opening the day marginally higher, stock markets in India have continued their momentum. Presently, they are trading near their all-time high levels.

Views on news

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

The Impact of GST On Banking transactions, Insurance, and Investments(Outside View)

Jul 11, 2017

PersonalFN explains how GST impacts your insurance premiums, investments, and banking transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Jul 24, 2017 01:57 PM

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - SANOFI INDIA COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS